Field safety notices: Mallinckrodt Pharmaceuticals Ireland Limited
Manufacturer registered in EUDAMED: SRN IE-MF-000000573 ; country: Ireland
3 authority publications by 3 authorities, from 12 Jun 2025 to 3 Jul 2026.
Latest notice: 3 Jul 2026, BfArM, CELLEX Photopheresis System Procedural Kit
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Mallinckrodt Pharmaceuticals Ireland Limited or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
- CELLEX Photopheresis System Procedural Kit
Source: BfArM – Safety instructions in the field · collected 16 Nov 2026
Corrective action: 2 publications by AEMPS, ANSM, from 12 Jun 2025 to 12 Jun 2025
- Chimiothérapie extracorporelle – Therakos Cellex Photopheresis Procedural Kit
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Kit para procedimiento de fotoaféresis THERAKOS CELLEX, código de producto CLXECP
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026